Arvalus Therapeutics
PrivateLast Round
Grant
Apr 4, 2025
Total Funding Raised
$2.51M
Company Overview
Arvalus Therapeutics is a drug discovery company developing Live Biotherapeutic Products (LBPs) to prevent infections before they occur.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
live biotherapeutic productLBPantimicrobial resistanceAMRmicrobiome therapeuticsbugs as drugsbacterial decolonizationinfection preventionmultidrug-resistant infectionssuperbugsgut microbiome therapypreclinical biotechoral biologicsepsis prevention
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Arvalus Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Arvalus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 4, 2025 | ||||
| Grant | Jan 24, 2025 | ||||
| Grant | Dec 21, 2024 |
Arvalus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| INCATE | Grant |
Arvalus Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Arvalus Therapeutics's valuation, stock price, and market status.